Since Smad1-/- astrocytes show enhanced antioxidant capacity, and astrocytes can protect against ischemic injury by releasing the antioxidant glutathione [3, 4], we next sought to test whether Smad1 deletion would attenuate stroke pathophysiology. Here, SMAD1 is linked to stroke disorder.